Director, Strategic Evidence and Collaborations, US Medical Affairs

At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference. Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together. Job Description We have an exciting opportunity within US Medical Affairs for a  Director, Medical Affairs Oncology, Strategic Evidence & Collaborations (SEC) . This role will be remote but will require headquarters travel for specific meetings quarterly.  Reporting to the Senior Director and Head of Strategic Evidence & Collaborations, US Medical Affairs (USMA), the core efforts of this role is to be responsible for co-developing the US Medical Affairs strategy for US Medical Affairs congress plans in collaboration with the COE (Congress Center of Excellence) and the USMA Strategy and Field Based Medical Teams.  The key functions of this role will be to represent and consider the healthcare environment of the US with internal and external stakeholders involved in cancer therapies across approved and pipeline molecules and indications, including the Global Medical Affairs team, US Medical Access and Quality team, Scientific Communications/Publications, Medical Affairs Outcomes Research, Commercial Strategy, Marketing, Value and Market Access,  Clinical Research/Development, US Public Affairs, US Government Affairs ,Patient Engagement, Business Conduct (Legal), and the field-based US Medical Science Liaisons.  Travel Requirement:  Must be able to travel more than 50% of the time, including a mix of domestic and international travel.  Job Responsibilities     As an integral part of the USMA Oncology team, and in close collaboration with Oncology medical directors, Field Medical., Global Medical Affairs, Medical Affairs Research, Medical Patient Access and Quality, and cross-functional partners, this role will establish and execute an overarching strategy for evidence generation across various tumor types in the US,  including collaboration  with cooperative groups, NCI/CTEP, and other key organizations. This role will also provide frequent internal and external input into the development of both the US and Global Medical Affairs Strategic Plans for our ADC portfolio, particularly the Integrated Strategic Plan (ISP). Additionally, the role will be a key contributor to the US and Global medical Plan of Action (POA)   Specific responsibilities for this role will include, but are not limited to:    Demonstrate deep subject matter expertise in our full ADC portfolio, the Gilead clinical trials and their clinical use, as well as competitive products  Collaborate as a thought partner and significant contributor to the successful work lead by the Community Cancer Collective Team (CCC)   Contribute to the development of the Global Integrated Strategic Plan (ISP) and Local Plan of Action (POAs) by providing US and Global based strategic perspectives   Develop strategies and implementation plans to define and address education, research, and medical affairs insights and data generation needs within the US   Prepare presentation materials and present scientific data at internal meetings and external advisory boards   Support US medical efforts in global and regional Congress strategic planning and tactical execution in collab with SEC lead and Center of Excellence (COE) for Congresses. The Role may focus on Disease Specific Efforts and Oncology HCPs engagement in collaboration across the USMA Teams.  Support-Lead the USMA medical efforts and strategic planning for US Based Oncology Societies   Provide medical and scientific leadership and support at key scientific meetings with US HCPs / patient presence   Serve as an information resource to Gilead colleagues, including the US Medical Science Liaisons, including medical educational activities, grants, and investigator-sponsored/collaborative studies.   Collaborate with Investigator Sponsored Research (which Gilead calls “Collaboration Research”) with the Medical Affairs Research Team (MAR) and Clinical R&D.  Upon limited occasion, Lead the delivery of timely, accurate, and succinct communication of fair-balanced clinical and scientific presentations to healthcare professionals, both proactively and in response to requests for information, consistent with promotional compliance and regulatory requirements   Upon occasion, participate in the editorial review of all scientific content to ensure strategic alignment and accuracy   Support the development of Disease-Specific Publication Strategy   Support data generation activities through:   Critical review of global collaboration Research, Ph 3b, and Ph4 study proposals generated in the US   Review abstracts and/or manuscripts that result from US collaboration research   Communicate Gilead’s commitment to scientific excellence through research and education   Provide strategic input to Global Medical Affairs Plan   Collaborate effectively and in a compliant manner with colleagues in other functional areas throughout Gilead.